In the case of KIF5A, the mutant C terminal resulting from ALS mutations has a reduced interaction with its motor domain, which results in increased motility through impaired autoinhibition (Baron et al., 2022; Pant et al., 2022). This evidence concerns the gene KIF5A and amyotrophic lateral sclerosis.